
### [MONDO:0001865](http://purl.obolibrary.org/obo/MONDO_0001865)
**Label:** autoimmune polyendocrine syndrome

**Subclasses:** [MONDO:0010012](http://purl.obolibrary.org/obo/MONDO_0010012) (autoimmune polyendocrinopathy type 2), [MONDO:0009411](http://purl.obolibrary.org/obo/MONDO_0009411) (autoimmune polyendocrine syndrome type 1), 

**Corr. equiv. classes:** [OMIM:269200](http://purl.obolibrary.org/obo/OMIM_269200), [Orphanet:3143](http://www.orpha.net/ORDO/Orphanet_3143), [OMIM:240300](http://purl.obolibrary.org/obo/OMIM_240300), [Orphanet:3453](http://www.orpha.net/ORDO/Orphanet_3453), 

**Class expressions from DL-Learner:**

- [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) and [HP:3000050](http://purl.obolibrary.org/obo/HP_3000050) (Abnormality of odontoid tissue) 62.50%
- [HP:0100651](http://purl.obolibrary.org/obo/HP_0100651) (Type I diabetes mellitus) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0100533](http://purl.obolibrary.org/obo/HP_0100533) (Inflammatory abnormality of the eye) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0031066](http://purl.obolibrary.org/obo/HP_0031066) (Abnormal ovarian physiology) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0025337](http://purl.obolibrary.org/obo/HP_0025337) (Red eye) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0012243](http://purl.obolibrary.org/obo/HP_0012243) (Abnormal reproductive system morphology) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0011767](http://purl.obolibrary.org/obo/HP_0011767) (Abnormality of the parathyroid physiology) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0011733](http://purl.obolibrary.org/obo/HP_0011733) (Abnormality of adrenal physiology) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0011495](http://purl.obolibrary.org/obo/HP_0011495) (Abnormality of corneal epithelium) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0011370](http://purl.obolibrary.org/obo/HP_0011370) (Recurrent cutaneous fungal infections) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%
- [HP:0011061](http://purl.obolibrary.org/obo/HP_0011061) (Abnormality of dental structure) and [HP:0200120](http://purl.obolibrary.org/obo/HP_0200120) (Chronic active hepatitis) 62.50%


